Integragen (XPAR:ALINT) PB Ratio: (As of Jul. 02, 2026)


XPAR:ALINT Integragen XPAR:ALINT
28 GF Score
Price €0.17
GF Value €0.42
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Integragen PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-02), Integragen's share price is €0.174. Integragen's Book Value per Share for the quarter that ended in Jun. 2025 was €-0.14. Hence, Integragen's PB Ratio of today is .

The historical rank and industry rank for Integragen's PB Ratio or its related term are showing as below:

During the past 13 years, Integragen's highest PB Ratio was 13.92. The lowest was 0.48. And the median was 3.61.

XPAR:ALINT's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.95
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, Integragen's average Book Value Per Share Growth Rate was -81.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -6.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -5.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -7.50% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Integragen was 22.20% per year. The lowest was -50.20% per year. And the median was -5.90% per year.

Back to Basics: PB Ratio


Integragen  (XPAR:ALINT) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Integragen PB Ratio Related Terms


Integragen PB Ratio Historical Data

* Premium members only.

The historical data trend for Integragen's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integragen PB Ratio Chart

Integragen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.36 3.68 2.94 2.12 0.00

Integragen Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.94 1.85 2.12 9.40 0.00

XPAR:ALINT vs VRTX, REGN, ALNY: PB Ratio Comparison

For the Biotechnology subindustry, Integragen's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integragen PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Integragen's PB Ratio distribution charts can be found below:

* The bar in red indicates where Integragen's PB Ratio falls into.


XPAR:ALINT
28GF Score
Integragen XPAR:ALINT
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integragen PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Integragen's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2025)
=0.174/-0.138
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Is Integragen (XPAR:ALINT) Overvalued in 2026?

Based on GuruFocus' analysis, Integragen stock appears to be undervalued. The current stock price of €0.17 is trading 58.6% below its estimated GF Value™ of €0.42. GuruFocus considers Integragen to be Possible Value Trap.

Key valuation signals for XPAR:ALINT:

  • PB Ratio:
  • GF Value™: €0.42 vs. price of €0.17 (58.6% below fair value)
  • GF Score™: 28/100 with 4 warning signs

No single metric tells the full story. See the XPAR:ALINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Integragen Business Description

Other Exchanges 7N8:Germany
Address Genopole Campus 1 - Genavenir, 85 rue Henri Desbrueres, Evry, FRA, 91000
Integragen is engaged in the development of genetic biomarkers. It offers genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics, and genomics news, as well as genomic research tools and solutions to microbiologic researchers.
28GF Score

Get the complete analysis for XPAR:ALINT

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.17
Price
€0.42
GF Value